Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting.

2015

Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

30

References

24

Citations